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We have used a previously described rodent model to examine the influence of hormonal environment on
susceptibility and immune responses to genital Chlamydia infection. Ovariectomized rats were administered
estradiol, progesterone, or a combination of both, infected with Chlamydia trachomatis via the intrauterine
route, and sacrificed 5 days later. Histopathological examination showed severe inflammation in the uteri and
vaginae of progesterone-treated animals, whereas animals receiving estradiol or a combination of both hor-
mones showed no inflammation. Large numbers of chlamydiae were found in vaginal secretions of progester-
one-treated and combination-treated animals, while estradiol-treated animals had none. Tissue localization
showed that numerous chlamydial inclusions were present in the uterine epithelium of the progesterone group
and the cervicovaginal epithelium of the combination group. Examination of the acute immune responses of the
infected animals showed that maximum activation was present in the draining lymph node cells from the
progesterone-treated group, and these cells were producing large amounts of interleukin-10 and gamma
interferon compared to other hormone-treated groups. In contrast, spleen cell proliferation was suppressed in
progesterone-treated animals compared to other hormone-treated groups. We conclude that progesterone
increases and estradiol decreases susceptibility to intrauterine chlamydial infection in this rat model. Our data
demonstrate that hormone environment, at the time of infection, has a profound effect on the outcome of
microbial infection in the female reproductive tract.
Mucosal surfaces represent the largest area of contact of
microbial agents with the body’s immune system. Among the
mucosal surfaces, the reproductive tract has possibly the most
specialized immune system, since it has evolved to meet the
dual challenge of providing continuous protection against po-
tential pathogens while providing a receptive environment for
allogeneic sperm and embryo. These requirements are met
partly by the precise and differential regulation of the immune
system in the reproductive tract by the ovarian hormones es-
tradiol and progesterone. Studies from our laboratory have
shown that antigen presentation, immunoglobulin A (IgA)
transport, and presence of immune cells in the uterus and
vagina are under organ-specific hormonal regulation (5, 6, 9,
29–31).
Chlamydia trachomatis is an obligate intracellular, gram-neg-
ative bacteria and the cause of the world’s most common sex-
ually transmitted bacterial infection (20). Genital chlamydial
infections are a major public health concern because of the
severe pathologic sequelae of the infection, including pelvic
inflammatory disease, scarring of the fallopian tubes, infertil-
ity, and ectopic pregnancy. Clinical symptoms range from acute
asymptomatic infection to chronic conditions characterized by
a severe inflammatory response (13).
In the last decade there has been an exponential growth in
our understanding of immune responses to chlamydial infec-
tion. Studies in mouse models have shown that the immune
response to genital chlamydial infection is very complex: it
clears infection and confers short-term protection but at the
same time sensitizes the host for development of immuno-
pathological changes (13). There is strong evidence that CD4
T-cell-mediated immunity plays a critical role in clearing in-
fection (3, 18, 21). Other studies in the mouse as well as other
animal models also show that hormones play an important role
in controlling immune responses to chlamydial infection and in
determining the outcome of infection (17). In general, mouse
models require pretreatment with progesterone prior to expo-
sure, to enhance infections, especially with human serovars
(16). Others have shown that in the absence of progesterone
pretreatment, establishment of infection is dependent on stage
of the estrous cycle or requires high infectious doses (4).
Guinea pigs do not require progesterone and are easily in-
fected with C. psittaci, but develop heavier infection following
estradiol treatment (2, 15). In human studies, an association
has been observed between onset of chlamydial infection and
stage of menstrual cycle (24). Enhanced susceptibility was ob-
served in the proliferative part of the menstrual cycle when
estradiol levels were high. Oral contraceptives have also been
shown to increase susceptibility to chlamydial infections and
other sexually transmitted diseases (27).
Our studies in the rat model have shown that under the
influence of progesterone, intrauterine exposure to C. tracho-
matis can induce infection in the genital tract (7). Immune
responses were detected locally and systemically, and the re-
sults indicated that clearance of infection in this model involves
immune cells from the lymph nodes draining the reproductive
tract. In the present study, we examined the role played by
the endocrine environment in determining susceptibility of the
genital tract and if this in turn could have an effect on the
outcome of infection. We also examined early immune re-
sponses locally and systemically to assess whether the hor-
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monal environment influences the immune responses at the
time when infection was induced.
MATERIALS AND METHODS
Animal and hormone administration. Adult female Lewis rats (Charles River
Laboratories, Kingston, N.Y.) weighing 150 to 200 g were maintained under
standard temperature-controlled conditions on a 12-h light:12-h dark cycle.
Ovariectomies were performed 7 to 10 days before each experiment as previously
described (8). Estradiol and progesterone were purchased from Calbiochem (La
Jolla, Calif.). Estradiol was initially dissolved in ethanol, evaporated to dryness,
and then resuspended in 0.9% saline. Progesterone was suspended in saline by
glass-glass homogenization. Control ovariectomized animals received only saline.
All hormones were administered by subcutaneous injection. To correct for the
alcohol present in estradiol preparation, an equivalent amount of ethanol was
evaporated in flasks used to prepare progesterone and saline.
Infection of animals. C. trachomatis (mouse pneumonitis nigg-II strain
[MoPn]) was purchased from the American Type Culture Collection (Manassas,
Va.). Females were administered either 2 mg of progesterone, 10 mg of estradiol,
or a combination of both for 3 consecutive days. On the second day of the
hormone treatment, animals were infected with MoPn (5 3 106 inclusion-form-
ing units [IFU]/uterine horn) via the intrauterine route as described elsewhere
(7).
In vitro infectivity assay to quantitate chlamydial shedding in vaginal washes.
Vaginal swabs from infected animals were collected in 0.5 ml of sucrose-phos-
phate-glutamate (SPG) buffer at various days postinfection. McCoy cells were
grown to confluency in 24-well plates. Vaginal washing samples were diluted
starting at 1:50 and added to monolayers in duplicate. A positive control con-
sisting of a previously titrated MoPn stock, as well as mock infection as a negative
control, was included on each plate. Infected monolayers were incubated for 72 h
and then stained with rabbit anti-Chlamydia antibody (Biodesign Inc., Kenneb-
unk, Maine) and an Immunopure ABC Rabbit Ig staining kit (Pierce Inc.,
Rockford, Ill.). Inclusions were revealed using an Immunopure Metal Enhanced
DAB kit (Pierce) and counted under a light microscope. Four to eight fields of
vision were counted for each sample, and IFU per milliliter was calculated.
Immunohistochemical staining. For immunohistochemical analysis, reproduc-
tive tract tissues were excised, rinsed in cold saline (0.9%) prior to processing
with acetone, methyl alcohol, and xylene, paraffin embedded, and stained as
previously described (9). Briefly, 6- to 8-mm sections were cut with a microtome
and placed on silane-coated slides. Sections were deparaffinized in xylene, rehy-
drated, and washed in 0.01 M phosphate-buffered saline–bovine serum albumin
(1 mg/ml). Nonspecific staining was blocked by incubating sections with 1%
rabbit serum for 20 min at room temperature. To detect chlamydial infection,
sections were stained with rabbit anti-C. trachomatis (Biodesign) polyclonal an-
tiserum (1:200) for 60 min. Antiserum from normal rabbits was substituted for
primary antibody at an equivalent concentration for control staining. Avidin-
biotin coupled to alkaline phosphatase (ABC Elite kit; Vector Laboratories,
Burlinghame, Calif.) followed by Vector Red (alkaline phosphatase kit; Vector
Laboratories) was used to reveal antigen localization. Monoclonal antibody ED1
(Serotec Laboratories, Oxford, England) was used for staining myeloid cells
(macrophages and blood granulocytes) in the reproductive tract. A horse anti-
mouse Ig coupled to biotin was used as a secondary antibody. Slides were
counterstained with methyl green and mounted in Permount medium prior to
microscopic examination.
Lymphocyte proliferation assays. To measure lymph node and spleen cell
proliferation, para-aortic lymph nodes (PALN) draining the genital tract and
spleens were removed aseptically from animals. Single-cell suspensions were
prepared by teasing with sterile forceps. Debris was allowed to settle for 2 min,
and supernatant containing single cells was recovered and spun down at 500 3
g for 10 min. Spleen cells were treated with ammonium chloride solution for 10
min to lyse the erythrocytes as previously described (7). Cells were washed three
times with RPMI 1640 medium containing 10% bovine serum albumin and
plated at a concentration of 105 cells/well in a 96-well plate together with either
1 mg of concanavalin A (ConA) per ml, 5 mg of phytohemagglutinin (PHA) per
ml, 10 mg of lipopolysaccharide (LPS) per ml, or 1 and 5 mg of major outer
membrane protein (MOMP) per ml. Proliferative responses were measured by
uptake of 1 mCi of [3H]thymidine per well for the last 18 to 24 h of a 3-day
culture. Results are reported as mean counts per minute 6 standard error of
triplicate cultures. Each experiment was repeated at least two times. Data were
analyzed using Student’s t test.
Cytokine analysis. Cytokine levels were measured using commercial enzyme-
linked immunosorbent assay (ELISA) kits from Endogen Inc. (Woburn, Mass.)
according to the protocol recommended in the kits. Briefly, 50- to 100-ml aliquots
of supernatants were collected from spleen or lymph node cultures 48 h after the
start of incubation. Supernatants were run in duplicates in ELISA assays for rat
interleukin (IL-10) and rat gamma interferon (IFN-g). Absorbency was read at
450 nm in an ELISA reader (Dynex Technologies), and data were analyzed by
Dynex Revelation software. The sensitivity of both assays was ,10 pg/ml with an
inter- and intra-assay coefficient of variation of ,10%.
RESULTS
Histopathological evaluation of rats infected with Chlamydia
following hormone treatment. Female Lewis rats were injected
with either saline, estradiol, progesterone, or estradiol plus
progesterone for 3 consecutive days. On the second day of
hormone treatment, rats were infected with C. trachomatis
MoPn (5 3 106 IFU/uterine horn) via the intrauterine route.
Rats were sacrificed 5 days later and examined for infection,
tissue pathology, and immune response. Control rats (hor-
mone treated, not infected) were also examined (results not
shown). Figure 1 shows the histology of the uterus (A to D)
and vagina (E to F) from the four groups of animals given
hormone treatment and infected with Chlamydia. The control
group (ovariectomized, saline treated, infected) (Fig. 1A and
E) showed mild to moderate inflammation in the uterus and
vagina characterized by an infiltration of granulocytes and a
few lymphocytes into the subepithelial stroma. Rats that were
estradiol treated and infected with Chlamydia had no inflam-
mation in either uterus or vagina (Fig. 1B and F). The proges-
terone-treated, Chlamydia-infected group had the most severe
inflammation. The uterine lumen of these rats had massive
infiltrations of polymorphonuclear (PMN) cells (Fig. 1C). The
glandular lumen (not shown) and the subepithelial stroma also
had PMN infiltration. The vaginae of these animals had mod-
erate inflammation with PMN infiltration (Fig. 1G). As was the
case with the estradiol-treated group, no inflammation was
observed in the combined hormone treatment group (Fig. 1D
and H). Control rats (hormone treated, not infected) did not
show any inflammatory infiltration in any of the treatment
groups (data not shown). In the hormone-treated, uninfected
control groups, a slight increase in number of leukocytes in the
uteri of estradiol-treated rats and vaginae of progesterone-
treated rats was noted. This was an expected effect of hor-
mones, described by us previously (5), not part of an inflam-
matory process; we took these increases into account when
grading for inflammation in infected rats. Results from two
separate experiments where the uterus and vagina of each
infected animal treated with hormone were histopathologically
evaluated are summarized in Table 1.
Cervicovaginal shedding of C. trachomatis in hormone-
treated animals. In vitro infectivity assays, described in Mate-
rials and Methods, were carried out to assess the level of
infection in hormone-treated rats. The detection of inclusion
bodies is illustrated in Fig. 2. As can be seen, cultures which
received vaginal washes from estradiol-treated animals (Fig.
2D) were essentially similar to negative control cultures (Fig.
2B). Cultures exposed to washes from saline-treated infected
animals showed inclusion bodies in large numbers (Fig. 2C).
All cultures which were exposed to vaginal washes from the
progesterone and combination groups, at the same dilution as
for estradiol- and saline-treated groups, had either partially
destroyed or completely destroyed monolayers demonstrating
large numbers of shed IFU (Fig. 2E and F). These assays were
repeated with further dilutions of vaginal flushes, and the
quantitative results are shown in Table 2. Six of the eight
saline-treated animals had titers of 109 IFU/ml or less. Titers
higher than 1010 IFU/ml were observed in the cervicovaginal
washings of all of eight animals from the progesterone-treated
group and in seven of the eight animals in the combined hor-
mone treatment group. We detected no organisms in the vag-
inal secretions from rats in the estradiol-treated group. These
results are from two separate experiments, each time with four
rats per group; vaginal secretions of each rat were monitored
separately.
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FIG. 1. Histopathology of uteri (A to D) and vaginae (E to F) of rats infected with C. trachomatis following intrauterine treatment with saline (A and E), estradiol
(B and F), progesterone (C and G), or estradiol and progesterone (D and H). Animals were sacrificed 5 days postinfection; reproductive tract tissues were removed,
fixed, processed for histology, and stained with hematoxylin and eosin. Representative tissue sections from each treatment groups are shown. Estrogenic effects on
epithelial cells of uteri and vaginae of rats receiving estradiol can be observed (B, D, F, and H). Note the acute inflammation in the uterus of a progesterone-treated
rat, characterized by large number of infiltrating leukocytes (C). s, stroma; l, lumen; e, epithelium. Original magnification, 3100.
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Tissue localization of chlamydial infection. Immunohisto-
chemical staining was done to localize chlamydial inclusion
bodies in the tissue sections from hormone-treated rats, using
a rabbit polyclonal antibody to Chlamydia (Fig. 3). While oc-
casional chlamydial inclusions were detected in the uteri of
saline-treated, infected rats (Fig. 3A), the uterine epithelium
of progesterone-treated rats had extensive infection (Fig. 3C).
Numerous inclusions were localized in the cervicovaginal epi-
thelium of the combined hormone treatment group (Fig. 3D).
There was no sign of infection in the uterine and vaginal
epithelium of the estradiol-treated rats, as evidenced by lack of
any detectable staining of inclusion bodies (Fig. 3B). The re-
sults from immunohistochemical assessment of all animals are
summarized in Table 3. No specific staining for chlamydial
antigens was observed below the epithelium in any of the
groups.
Characterization of tissue inflammation in hormone-treated,
Chlamydia-infected rats. To characterize the inflammatory re-
sponse seen in the hormone-treated animals infected with
C. trachomatis, we examined tissue sections from the uteri and
vaginae of the four experimental groups, using immunohisto-
chemical staining for ED1, a marker for macrophages and
blood granulocytes, as described in Materials and Methods
(Fig. 4). Very few ED1-positive cells were found within the
uterine subepithelial stroma of saline-treated, infected rats
(Fig. 4A). Chlamydia-infected rats from the estradiol-treated
group and combined hormone group had an increased num-
bers of ED1-positive cells compared to the saline group (Fig.
4B and D). These cells were uniformly scattered throughout
the stroma and did not appear to be part of a localized inflam-
matory response. Increase in the local immune cell population
under the influence of estradiol has been previously reported
(5). In contrast, progesterone-treated, Chlamydia-infected an-
imals had large numbers of ED1-positive cells in the tissue and
in the uterine lumen (Fig. 4C). These cells were concentrated
in the subepithelial layer (Fig. 4C, a) and in the leukocytic
infiltration present in the lumen (Fig. 4C, b). A similar increase
in the distribution of ED1 cells was observed in the subepithe-
lial stroma of the vagina of saline-treated rats (not shown) and
progesterone-treated infected rats (Fig. 4F), while no increase
in ED1-positive cells was observed in the vaginal mucus of
estradiol-treated (Fig. 4E) and combination-treated (not shown)
groups. These results indicate that an acute inflammatory re-
sponse characterized by the presence of granulocytes and mac-
rophages is present in the genital tract of progesterone-treated,
infected animals and to a lesser extent in saline-treated, in-
fected animals.
Lymphocytic proliferation in hormone-treated, Chlamydia-
infected rats. To examine the immune response in hormone-
treated, Chlamydia-infected rats, PALN, which drain the gen-
ital tract, and spleen cells were isolated and stimulated by
mitogens or chlamydial MOMP antigen. Figure 5A shows the
lymphocyte proliferation response by the PALN cells of the
different experimental groups. Maximum mitogenic as well as
MOMP-specific responses were observed in PALN cells from
progesterone-treated, infected rats. Enhanced mitogenic pro-
liferation was also observed in the estradiol and combination
groups compared to lymph node cells from saline-treated, in-
fected rats that were the least activated. Spleen cells (Fig.
5B), on the other hand, gave much lower proliferation to
both mitogens (ConA, LPS, and PHA) and MOMP compared
to PALN cells. Proliferation was significantly suppressed in
spleen cell cultures from progesterone-treated, Chlamydia-in-
fected rats. Spleen cells from estradiol-treated and combined
hormone treatment rats had the highest proliferation to mito-
gens as well as MOMP-specific challenge.
Cytokine secretion by lymph node and spleen cells of hor-
mone-treated, Chlamydia-infected rats. In experiments run in
parallel with the proliferation assays, PALN cells and spleen
cells were cultured from the four groups of infected rats, sac-
rificed 5 days postinfection. The cells were cultured for 48 h in
the presence or absence of MOMP and the supernatants ex-
amined for IL-10 and IFN-g. As shown in Fig. 6, large amounts
of IL-10 and IFN-g were produced by PALN cells from pro-
gesterone-treated, infected rats, following MOMP challenge
relative to other hormone-treated groups. Cells from the pro-
gesterone-treated rats also had elevated IFN-g production in
the absence of MOMP compared to cells from other groups.
PALN cells from estrogen and combined hormone-treated rats
produced IFN-g at levels similar to untreated controls. PALN
cells produced very little IL-10 in the absence of MOMP.
Supernatants from spleen cells showed elevated levels of IL-10
in all three hormone-treated group following MOMP chal-
lenge. The highest IFN-g levels were seen with MOMP chal-
lenge of spleen cells from progesterone-treated, Chlamydia-
infected rats. IFN-g produced by spleen cells taken from the
estrogen or combined hormone treatment rats was similar to
that produced by spleen cells from untreated, infected rats.
These results indicate that Chlamydia infection in progester-
one-treated rats increased the Chlamydia-specific production
TABLE 1. Histopathology of hormone-treated rats, day 5 postinfection
Groupa Tissue
Histopathology gradeb
Overall assessment
Lymphocytes Granulocytes Tissuenecrosis Inflammation
Saline Uterus 11 11 1 11 Mild/moderate inflammation
Vagina 11 111 1 11 Moderate inflammation
E Uterus 1 1 2 2 Normal
Vagina 1 2 2 2 Normal
P Uterus 1 1111 111 1111 Moderate/severe inflammation
Vagina 11 111 1 111 Moderate inflammation
E1P Uterus 1/2 1 2 2 Normal
Vagina 1/2 1/2 2 2 Normal
a E, estradiol; P, progesterone.
b 2, no inflammatory cells/HPF (high-power field), no epithelial invasion, no tissue necrosis; 2/1, ,5 inflammatory cells/HPF, no epithelial invasion, no tissue
necrosis; 1/2, ,10 inflammatory cells/HPF, minimal epithelial invasion, no tissue necrosis, focal apoptosis present; 1, ,20 inflammatory cells/HPF, focal epithelial
invasion, no tissue necrosis, focal apoptosis present; 11, .20 inflammatory cells/HPF, focal epithelial invasion, focal tissue necrosis; 111, .20 inflammatory
cells/HPF, moderate epithelial invasion, focal tissue necrosis, apparent tissue edema, purulent exudate; 1111, .20 inflammatory cells/HPF, marked epithelial
invasion, marked tissue destruction, pus or abscess formation, marked tissue edema. The assessment was made from tissue samples of all animals in the same group
(n 5 4). The experiment was repeated twice.
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of IFN-g and IL-10 in the draining nodes and to a lesser extent
IFN-g production by spleen cells.
DISCUSSION
These studies provide direct evidence that the hormonal
environment at the time of pathogen exposure can have a
distinct effect on the outcome of a microbial infection in the
genital tract. We found that in the absence of any endogenous
hormones, ovariectomized rats were susceptible to genital
chlamydial infection, as indicated by mild infection and low-
grade inflammation in uterus and vagina. Giving estradiol to
ovariectomized rats led to complete protection from chlamyd-
ial infection, and none of the animals showed any signs of
inflammation in the uterus or the vagina. When progesterone
alone was administered, animals became heavily infected, and
infection was accompanied by an acute inflammatory response.
In marked contrast, in the presence of both estradiol and
progesterone, the rats became heavily infected but did not
show any inflammatory response. These results suggest that
estradiol and progesterone have separate and distinct effects
on susceptibility to infection and inflammation. While estradiol
decreases susceptibility, it also seems to have a strong anti-
inflammatory response. This effect seems to be distinct from
FIG. 2. In vitro infectivity assay to assess bacterial shedding in vaginal washes of hormone-treated, infected rats. Vaginal washes from day 5 postinfection were
layered on monolayers of McCoy cells and stained with an anti-Chlamydia antibody as described in Materials and Methods. Micrographs show stained monolayers from
cultures layered with washings (all at same dilution) from animals infected with Chlamydia after treatment with saline (C), estradiol (D), progesterone (E), and estradiol
plus progesterone (F). Positive (previously titered stock; A) and negative (mock infection; B) controls are also shown. Darkly stained inclusion bodies can be clearly
distinguished in infected monolayers. Note that panels E and F are partially destroyed monolayers, indicating presence of too many IFU. These and similar samples
were diluted further and retitered to obtain final titers. Results from estradiol-treated animals (D) were found to be similar to negative control results in all samples.
The dark staining seen in panels B and D was due to staining of dead cells and was subtracted as background when titers were calculated.
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the protective effect, because inflammation was absent even in
the presence of infection in the combination hormone group.
Progesterone, on the other hand, seems to enhance both sus-
ceptibility and inflammatory responses. Alternatively, proges-
terone may enhance infection, leading to increased inflam-
mation. With the combination of hormones used in these
experiments, estradiol effect on inflammation predominates
whereas progesterone affects primarily susceptibility. These
findings have important implications in view of the fact that in
women, chlamydial infections are often silent, and subsequent
reinfections lead to inflammatory responses with pathological
sequelae such as pelvic inflammatory disease, scarring of fal-
lopian tubes, and ectopic pregnancy (12, 13). Further charac-
terization of this model could provide a new approach to un-
derstanding asymptomatic chlamydial infections, which have
been difficult to study because of the lack of an appropriate
animal model.
Previous studies have shown that sex hormones influence
susceptibility to microbial infections in the reproductive tract
in a number of species. Mice treated with progesterone were
found to have higher mortality rates when infected intravagi-
nally with herpes simplex virus type 2 (1). In other studies,
genital tract susceptibility to Neisseria gonorrhoeae was en-
hanced in mice at proestrus, when estrogen levels are high
(10). Rank et al. have shown that guinea pigs are more sus-
ceptible to chlamydial infection following estradiol treatment,
while other studies show that infection can be established in
mice only after progesterone pretreatment (17, 19). Studies of
humans show that women are also more susceptible to infec-
tion under estradiol influence, since more chlamydial organ-
isms can be isolated from the proliferative part of the cycle
(24). The exact mechanism by which different hormones affect
FIG. 3. Localization of infection in the reproductive tracts of hormone-treated, infected rats by immunohistochemical staining of chlamydial antigens. Polyclonal
antibody was used to detect Chlamydia-specific staining as described in Materials and Methods. Representative tissue sections showing typical staining for each group
are shown in the micrographs. Positive (pink) staining can be seen in the uterine epithelium of progesterone-treated animals (C) and cervicovaginal epithelium of
estradiol-progesterone-treated animals (D). Very little positive staining was seen in saline-treated animals (A). Uteri and vaginae of estradiol-treated animals were
negative in all sections examined. s, stroma; l, lumen; e, epithelium. Original magnification, 3100.
TABLE 2. Detection of Chlamydia in vaginal washes
from hormone-treated, infected ratsa
Group
No. of rats
ND 108 IFU/ml 109 IFU/ml .1010 IFU/ml
S 0 1 5 2
E 8 0 0 0
P 0 0 0 8
E 1 P 0 0 1 7
a Experimental groups consisted of ovariectomized female rats given saline
(S), estradiol (E), progesterone (P), or a combination of both (E1P), as de-
scribed in Materials and Methods. Each group had a total of eight rats in two
experiments, and vaginal wash from each animal was monitored separately. ND,
not detected. 1010 was the highest detection limit for this assay at a vaginal wash
dilution of 1:10,000.
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susceptibility in a species-specific manner is not understood. In
our studies, rats infected at estrus and diestrus stages of the
cycle without prior progesterone priming did not show any
signs of active infection, although enhanced local immune re-
sponse was noted (7). However, following progesterone prim-
ing, rats are susceptible to genital C. trachomatis infection.
Chlamydial inclusions were detected in the uteri and vaginas of
infected animals, and at the same time immune responses
could be detected locally and systemically (7). In other studies,
we have found that rats are susceptible to genital chlamydial
infection when exposed by both intrauterine and intravaginal
route, following progesterone pretreatment (C. Kaushic and
C. R. Wira, unpublished data). However, intravaginal exposure
led to a lower infection and a faster clearance compared to
intrauterine exposure.
The mechanisms by which progesterone enhances suscepti-
bility and estradiol protects against genital tract infections in
rodents are not clear. It has been suggested that under the
influence of progesterone, the epithelial lining of the genital
tract is thinned and stabilized in a diestrus condition, allowing
infection to become established. While this is possible, there
may be additional factors influencing susceptibility and type of
immune response following infection. Studies from our labo-
ratory have shown that sex hormones have profound effects, on
both the inductive and the effector arm of the mucosal immune
system in the reproductive tract, that may affect the outcome of
infections (29). We have shown that antigen presentation in
the uterus and vagina is influenced by estradiol and progester-
one (30, 31). IgA and IgG levels, IgA transport, and immune
cell trafficking in the genital tract are also regulated by estra-
diol and progesterone (5, 6, 8, 32). Moreover, this regulation is
tissue specific because, while estradiol enhances and proges-
terone suppresses immune response in the uterus, they affect
the lower reproductive tract in opposite manners. Recently
similar results have been reported for the reproductive tract of
women. Antigen-independent CD31 T-lymphocyte cytolytic
activity was found to be higher during the proliferative phase
under the influence of estradiol and absent in the secretory
phase of the menstrual cycle when progesterone levels are high
(28). Thus, depending on hormonal environment at the site of
exposure in the reproductive tract, the local mucosal immune
system may be altered, which could lead to increased or de-
creased protection, with or without inflammation as seen in the
present study.
One of the possible mechanisms which may account for the
differences in susceptibility seen under different hormone in-
fluences may be differential expression of receptors on epithe-
lial cells in the genital tract which mediate chlamydial entry
(33). Chlamydial infection is initiated by contact, attachment
and entry of infectious elementary bodies (EBs) into the host
epithelial cell. The exact mechanism of attachment and entry is
still not clear, although several likely possibilities have been
suggested. Of these, the most promising one involves a glycos-
aminglycan-mediated mechanism (36). Studies show that a
heparan sulfate-like glycosaminglycan on the surface of EBs
binds to a heparan sulfate receptor on the epithelial cells.
Other studies have provided evidence for the possibility that
chlamydial MOMP is the adhesion molecule that binds to
heparan sulfate proteoglycans on the epithelial surface (22).
Interestingly, reproductive tract tissues have been shown to
express a whole family of proteoglycans belonging to epider-
mal growth factor (EGF) family, including EGF, transforming
growth factor b, heparin-binding EGF, and their receptors (11,
26, 34). Some of these, like heparin-binding EGF and heparin
affin regulatory peptide, HARP have been demonstrated to be
under estradiol and/or progesterone regulation (11, 34, 35).
Examining the expression of these proteoglycans in this system
under different hormone conditions and correlating with infec-
tion could provide important information on the mechanism of
chlamydial susceptibility in the reproductive tract.
When early immune responses were examined in the present
study, lymphocyte activation and enhanced cytokine release
were observed in the draining lymph node cells of progester-
one-treated animals, in response to both mitogenic and chla-
mydial antigen-specific stimulation. At the same time, prolif-
eration of spleen cells was suppressed. These results show that
in the absence of any other hormone effect, infection with
Chlamydia, following progesterone pretreatment, leads to in-
duction of local immune response (seen in draining lymph
nodes) while at the same time there is a systemic suppression
(seen in the spleen). That progesterone enhanced local im-
mune response in the uterus and draining lymph nodes is
somewhat surprising, since others have shown that it is asso-
ciated with immunosuppressive effects on immune responses
(for a review, see reference 14). We have shown in previous
studies that progesterone treatment of ovariectomized animals
leads to decreased IgA and polymeric Ig receptor mRNA and
protein levels in the uterus (8). Under the influence of proges-
terone, antigen presentation by uterine cells is decreased;
fewer immune cells are present in the rat uterus at diestrus
when progesterone levels are high (5, 31). An alternate expla-
nation to the contrast observed in local lymph node and spleen
cell responses in this study may be that while progesterone has
a suppressive effect on both, the suppressive effect is obvious
only in the spleen; in the lymph nodes, it is masked by the local
immune response to Chlamydia. The present data show that
any local immunosuppression by progesterone is overridden in
the presence of microbial infection in the genital tract. These
results extend our previous finding that nonovariectomized,
intact rats infected with chlamydia exhibited a modest activa-
tion of local immune system and suppression of the systemic
immune system following progesterone treatment (7).
The present study also indicates that under the influence of
estradiol, there is a greater systemic immune response to gen-
ital infection whereas progesterone leads to a specific local
immune activation (7). This can be concluded from the results
where enhanced mitogenic responses were found in the drain-
ing lymph node cells of the estradiol and combination hor-
mone-treated group, but these cells did not show enhanced
activation or produce significant amounts of the cytokines
IFN-g and IL-10 in response to chlamydial challenge. On the
other hand, spleen cells from both groups that received estra-
diol showed high proliferation rates as well as enhanced IFN-g
and IL-10 secretion in response to chlamydial challenge.
TABLE 3. Immunohistochemical analysis of inclusion
bodies in hormone-treated rats
Groupa Tissue No. of IBb Overall histologic assessment
S Uterus 3 Mild infection with inflammation
Vagina 28 Extensive infection with inflammation
E Uterus 0 No infection, no inflammation
Vagina 0 No infection, no inflammation
P Uterus 8 Moderate infection with inflammation
Vagina 30 Extensive infection with inflammation
E1P Uterus 7 Faint staining, no inflammation
Vagina 48 Extensive focal infection, no inflammation
a Experimental groups consisted of ovariectomized rats treated with saline (S),
estradiol (E), progesterone (P), or estradiol and progesterone (E1P).
b Total number of inclusion bodies (IB) counted on each slide stained with
anti-Chlamydia antibody, as described in Materials and Methods. Each slide had
at least one representative tissue section from each animal (n 5 4).
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FIG. 4. Localization of ED1-positive cells (macrophages and blood granulocytes) in the uteri (A to D) and vaginae (E and F) of hormone-treated, infected rats.
Positively stained cells (pink) can be seen in uteri of animals treated with saline (A), estradiol (B), progesterone (C), or estradiol and progesterone (D). Micrographs
of representative tissue sections from vaginae of estradiol-treated (E) and progesterone-treated (F) animals stained for ED1-positive cells are also shown. Note the
accumulation of large number of positively stained cells in the subepithelial stroma (C, a) and the leukocytic infiltration in the lumen (C, b) of uteri of progesterone-
treated animals. s, stroma; l, lumen; e, epithelium. Original magnification, 3100.
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Studies in murine models of MoPn infection have shown
that resistance to and clearance of infection are heavily depen-
dent on Th1-like cytokines. IL-12 is important for initial clear-
ance of bacteria, while IFN-g is important for long-term res-
olution of infection (18). Other studies have demonstrated that
while cell-mediated immune responses are capable of resolving
chlamydial infection, mice are more susceptible to reinfection
in the absence of specific antibody (23). It is less clear if there
is an association between a Th1 response and immunopathol-
ogy. One study showed that in a monkey model, repeated C.
trachomatis infection of fallopian tubes led to a Th1 cytokine
response associated with fibrosis and scarring (25). Chlamydial
LPS, endotoxin, and heat shock hsp60 and -70 have also been
implicated with inflammation and pathological consequences
(25). The results of the present study show that the early
immune response in progesterone-treated rats infected with
Chlamydia appears to be a mixed type, with both IFN-g and
IL-10 being secreted by the local lymph nodes in large amounts
on day 5 postinfection. Further studies are needed to charac-
terize the cytokine profile at a later stage in infection under
different hormonal conditions to see if inflammation persists
and correlates with Th1-type profile in this model.
To summarize, our results show that estradiol decreases
susceptibility to genital chlamydial infection and reduces ac-
companying inflammation, while progesterone increases sus-
ceptibility and promotes an inflammatory response following
infection. The differences seen under different hormone con-
ditions in the infectivity, inflammation, and early immune re-
sponses in the present study make this a very useful system to
identify the mechanism of susceptibility and inflammation.
FIG. 5. Lymph node (A) and spleen (B) cell proliferation assay in response to mitogens and MOMP in hormone-treated, infected animals. Four animals were used
for each treatment group. Results shown are representative of two separate experiments. Spleen or lymph node cells were isolated as described in Materials and
Methods and incubated in the presence of medium alone (control), ConA (1 mg/ml), PHA (5 mg/ml), LPS (10 mg/ml), MOMP-1 (1 mg/ml), and MOMP-2 (5 mg/ml).
p, P , 0.01; #, P , 0.05 compared to progesterone-treated group. E, estradiol; P, progesterone.
FIG. 6. IFN-g and IL-10 measurements in supernatants from PALN and spleen cells of hormone-treated, infected animals. Both IFN-g and IL-10 were in measured
in PALN and spleen cell cultures from day 5 postinfection, incubated with or without MOMP (1 mg/ml). E, estradiol; P, progesterone.
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These findings have important implications for future vaccine
strategies against genital infections. Using knowledge about
the hormonal environment most likely to induce protective
immune responses without the associated immunopathology
may lead to more effective vaccines.
ACKNOWLEDGMENTS
We are grateful to Richard Rossoll and Dathao Ho for technical
assistance; we thank Denis P. Snider for valuable suggestions and
critical reading of the manuscript.
Photomicroscopy was done in the Herbert C. Englert Cell Analysis
Laboratory, which is supported in part by a core grant from Norris
Cotton Cancer Center (CA 23108) and by equipment grants from the
Fannie E. Rippel Foundation. This work was supported by research
grant AI-13541 from NIH (C.R.W.) and a research grant from the
Hitchcock Foundation (C.K.).
REFERENCES
1. Baker, D. A., and S. A. Plotkin. 1978. Enhancement of vaginal infection in
mice by herpes simplex virus type II with progesterone. Proc. Soc. Exp. Biol.
Med. 158:131–134.
2. Barron, A., J. N. Pasley, R. G. Rank, H. J. White, and R. E. Mrak. 1988.
Chlamydial salpingitis in female guinea pigs receiving oral contraceptives.
Sex. Transm. Dis. 15:169–173.
3. Igietseme, J. U., and R. G. Rank. 1991. Susceptibility to reinfection after a
primary chlamydial genital infection is associated with a decrease of antigen-
specific T cells in the genital tract. Infect. Immun. 59:1346–1351.
4. Ito, J. J. I., R. Harrison, E. R. Alexander, and L. J. Billings. 1984. Estab-
lishment of genital tract infection in the CF-1 mouse by intravaginal inocu-
lation of a human oculogenital isolate of chlamydia trachomatis. J. Infect.
Dis. 150:577–582.
5. Kaushic, C., E. Frauendorf, R. M. Rossoll, J. M. Richardson, and C. R.
Wira. 1998. Influence of estrous cycle on the presence and distribution of
immune cells in the rat reproductive tract. Am. J. Reprod. Immunol. 39:
209–216.
6. Kaushic, C., E. Frauendorf, and C. R. Wira. 1997. Polymeric immunoglob-
ulin A receptor in the rodent reproductive tract: influence of estradiol in the
vagina and differential expression of messenger ribonucleic acid expression
in rodent uteri. Biol. Reprod. 57:958–966.
7. Kaushic, C., A. D. Murdin, B. J. Underdown, and C. R. Wira. 1998. Chla-
mydia trachomatis infection in the female reproductive tract of rat: influence
of progesterone on infectivity and immune response. Infect. Immun. 66:893–
898.
8. Kaushic, C., J. M. Richardson, and C. R. Wira. 1995. Regulation of poly-
meric immunoglobulin A receptor messenger ribonucleic acid expression in
rodent uteri: effect of sex hormones. Endocrinology 136:2836–2844.
9. Kaushic, C., and C. Wira. 1995. Effect of sex hormones on immune cells and
cytokines in the female reproductive tract. Clin. Immunol. Pathol. 76:S57.
10. Kita, E., H. Matsuura, and S. Kashiba. 1981. A mouse model for the study
of gonococcal genital infection. J. Infect. Dis. 143:67–70.
11. Milhiet, P. E., F. Vacherot, J.-P. Caruelle, D. Barritault, and D. Caruelle.
1998. Upregulation of the angiogenic factor heparin affin regulatory peptide
by progesterone in rat uterus. J. Endocrinol. 158:389–399.
12. Morell, V. 1995. Attacking the causes of “silent” infertility. Science 269:775–
777.
13. Morrison, R. P., D. S. Manning, and H. D. Caldwell. 1992. Immunology of
Chlamydia trachomatis infections, p. 57–84. In T. C. Quinn (ed.), Sexually
transmitted diseases. Raven Press, Ltd., New York, N.Y.
14. Olsen, N. J., and W. J. Kovacs. 1996. Gonadal steroids and immunity.
Endocrine Rev. 17:369–384.
15. Pasley, J. N., R. G. Rank, A. J. J. Hough, C. Cohen, and A. L. Barron. 1985.
Effects of various doses of estradiol on chlamydial genital infection in ovari-
ectomized guinea pigs. Sex. Transm. Dis. 12:8–13.
16. Patton, D. L., and A. B. Lichtenwalner. 1998. Animal models for the study of
chlamydial research, p. 641–650. In R. S. Stephens, G. I. Byrne, G. Chris-
tiansen, et al. (ed.), Chlamydial infections. Proceedings of Ninth Interna-
tional Symposium on Human Chlamydial Infection. Cambridge University
Press, Cambridge, England.
17. Patton, D. L., and R. G. Rank. 1992. Animal model for study of pelvic
inflammatory disease, p. 85–111. In T. C. Quinn (ed.), Sexually transmitted
diseases. Raven Press, New York, N.Y.
18. Perry, L. L., K. Feilzer, and H. D. Caldwell. 1997. Immunity to Chlamydia
trachomatis is mediated by T helper 1 cells through IFN-g-dependent and
-independent pathways. J. Immunol. 158:3344–3352.
19. Rank, R. G., H. J. White, A. J. J. Hough, J. N. Pasley, and A. L. Barron. 1982.
Effect of estradiol on chlamydial genital infection of female guinea pigs.
Infect. Immun. 38:699–705.
20. Schachter, J., and J. T. Grayston. 1998. Epidemiology of human chlamydial
infections, p. 3–10. In R. S. Stephens, G. I. Byrne, G. Christiansen, et al.
(ed.), Chlamydia infections. Proceedings of the Ninth International Sympo-
sium on Human Chlamydial Infection. Cambridge University Press, Cam-
bridge, England.
21. Su, H., and H. D. Caldwell. 1995. CD41 T cells play a significant role in
adoptive immunity to Chlamydia trachomatis infection of the mouse genital
tract. Infect. Immun. 63:3302–3308.
22. Su, H., and H. D. Caldwell. 1998. Sulfated polysaccharides and a synthetic
sulfated polymer are potent inhibitors of Chlamydia trachomatis infectivity in
vitro but lack protective efficacy in an in vivo murine model of chlamydial
genital tract infection. Infect. Immun. 66:1258–1260.
23. Su, H., K. Feilzer, H. D. Caldwell, and R. P. Morrison. 1997. Chlamydia
trachomatis genital tract infection of antibody-deficient gene knockout mice.
Infect. Immun. 65:1993–1999.
24. Sweet, R. L., M. Blankfort-Doyle, M. O. Robbie, and J. Schachter. 1986. The
occurrence of chlamydial and gonococcal salpingitis during the menstrual
cycle. JAMA 255:2246–2250.
25. Van Voorhis, W. C., L. K. Barrett, Y. T. Cosgrove Sweeney, C. C. Kuo, and
D. L. Patton. 1997. Repeated Chlamydia trachomatis infection of Macaca
nemestrina fallopian tubes produces a Th1-like cytokine response associated
with fibrosis and scarring. Infect. Immun. 65:2175–2182.
26. Wang, X.-N., S. K. Das, D. Damm, M. Kagsburn, J. A. Abraham, and S. K.
Dey. 1994. Differential regulation of heparin-binding epidermal growth fac-
tor-like growth factor in the adult ovariectomized mouse uterus by proges-
terone and estrogen. Endocrinology 135:1264–1271.
27. Washington, A. E., S. Gove, J. Schachter, and R. L. Sweet. 1985. Oral
contraceptives, Chlamydia trachomatis infection, and pelvic inflammatory
disease. A word of caution about protection. JAMA 1985:2062–2065.
28. White, H. D., K. M. Crassi, A. L. Givan, J. E. Stern, J. L. Gonzales, V. A.
Memoli, W. R. Green, and C. R. Wira. 1997. CD31CD81 CTL activity
within the human female reproductive tract: influence of stage and men-
strual cycle and menopause. J. Immunol. 158:3017–3027.
29. Wira, C. R., and C. Kaushic. 1996. Mucosal immunity in the female repro-
ductive tract: effect of sex hormones on immune recognition and responses,
p. 375–386. In H. Kiyono, P. L. Ogra, and J. R. McGhee (ed.), Mucosal
vaccines: new trends in immunization. Academic Press, New York, N.Y.
30. Wira, C. R., and R. Rossoll. 1995. Antigen presenting cells in the female
reproductive tract: influence of sex hormones on antigen presentation in the
vagina. Immunology 84:505–508.
31. Wira, C. R., and R. M. Rossoll. 1995. Antigen presenting cells in the female
reproductive tract: influence of estrous cycle on antigen presentation by
uterine epithelial and stromal cells. Endocrinology 136:4526–4534.
32. Wira, C. R., and C. P. Sandoe. 1977. Sex steroid hormone regulation of
immunoglobin G (IgG) and A (IgA) in rat uterine secretions. Nature 268:
534–536.
33. Wyrick, P. B. 1998. Cell biology of chlamydial infection: a journey in the host
epithelial cell by the ultimate cellular microbiologist, p. 69–78. In R. S.
Stephens, G. I. Byrne, G. Christiansen et al. (ed.), Chamydial infections.
Proceedings of Ninth International Symposium on Human Chlamydial In-
fection. Cambridge University Press, Cambridge, England.
34. Zhang, J. P., C. Funk, S. Glasser, and J. Mulholland. 1994. Heparin-binding
epidermal growth factor-like growth factor is differentially regulated by pro-
gesterone and estradiol in rat uterine epithelial and stromal cells. Endocri-
nology 134:1089–1094.
35. Zhang, J. P., C. Funk, S. Glasser, and J. Mulholland. 1994. Progesterone
regulation of heparin-binding epidermal growth factor-like growth factor
gene expression during sensitization and decidualization in the rat uterus:
effects of the antiprogestin, ZK 98.299. Endocrinology 135:1256–1263.
36. Zhang, J. P., and R. S. Stephens. 1992. Mechanism of C. trachomatis at-
tachment to eukaryotic host cells. Cell 69:861–869.
Editor: J. D. Clements
4216 KAUSHIC ET AL. INFECT. IMMUN.
